Erratum to: Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: Results from an open-ended, multicenter, Phase II extension study (Pituitary DOI: 10.1007/s11102-013-0478-0)

Stephan Petersenn; Andrew J. Farrall; Christophe De Block; Shlomo Melmed; Jochen Schopohl; Philippe Caron; Ross Cuneo; David Kleinberg; Annamaria Colao; Matthieu Ruffin; Karina Hermosillo Reséndiz; Gareth Hughes; Ke Hu; Ariel Barkan

doi:10.1007/s11102-013-0491-3

Erratum to: Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: Results from an open-ended, multicenter, Phase II extension study (Pituitary DOI: 10.1007/s11102-013-0478-0)

Stephan Petersenn^*, Andrew J. Farrall, Christophe De Block, Shlomo Melmed, Jochen Schopohl, Philippe Caron, Ross Cuneo, David Kleinberg, Annamaria Colao, Matthieu Ruffin, Karina Hermosillo Reséndiz, Gareth Hughes, Ke Hu, Ariel Barkan

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	141
Number of pages	1
Journal	Pituitary
Volume	17
Issue number	2
DOIs	https://doi.org/10.1007/s11102-013-0491-3
Publication status	Published - 2014

Access to Document

10.1007/s11102-013-0491-3

Cite this

Petersenn, S., Farrall, A. J., De Block, C., Melmed, S., Schopohl, J., Caron, P., Cuneo, R., Kleinberg, D., Colao, A., Ruffin, M., Hermosillo Reséndiz, K., Hughes, G., Hu, K., & Barkan, A. (2014). Erratum to: Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: Results from an open-ended, multicenter, Phase II extension study (Pituitary DOI: 10.1007/s11102-013-0478-0). Pituitary, 17(2), 141. https://doi.org/10.1007/s11102-013-0491-3

@article{27a08df356e642cdadf847bec1fb1f1e,

title = "Erratum to: Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: Results from an open-ended, multicenter, Phase II extension study (Pituitary DOI: 10.1007/s11102-013-0478-0)",

author = "Stephan Petersenn and Farrall, {Andrew J.} and {De Block}, Christophe and Shlomo Melmed and Jochen Schopohl and Philippe Caron and Ross Cuneo and David Kleinberg and Annamaria Colao and Matthieu Ruffin and {Hermosillo Res{\'e}ndiz}, Karina and Gareth Hughes and Ke Hu and Ariel Barkan",

year = "2014",

doi = "10.1007/s11102-013-0491-3",

language = "English",

volume = "17",

pages = "141",

journal = "Pituitary",

issn = "1386-341X",

publisher = "Kluwer Academic Publishers",

number = "2",

}

Petersenn, S, Farrall, AJ, De Block, C, Melmed, S, Schopohl, J, Caron, P, Cuneo, R, Kleinberg, D, Colao, A, Ruffin, M, Hermosillo Reséndiz, K, Hughes, G, Hu, K & Barkan, A 2014, 'Erratum to: Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: Results from an open-ended, multicenter, Phase II extension study (Pituitary DOI: 10.1007/s11102-013-0478-0)', Pituitary, vol. 17, no. 2, pp. 141. https://doi.org/10.1007/s11102-013-0491-3

Erratum to: Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: Results from an open-ended, multicenter, Phase II extension study (Pituitary DOI: 10.1007/s11102-013-0478-0). / Petersenn, Stephan; Farrall, Andrew J.; De Block, Christophe et al.
In: Pituitary, Vol. 17, No. 2, 2014, p. 141.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Erratum to

T2 - Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: Results from an open-ended, multicenter, Phase II extension study (Pituitary DOI: 10.1007/s11102-013-0478-0)

AU - Petersenn, Stephan

AU - Farrall, Andrew J.

AU - De Block, Christophe

AU - Melmed, Shlomo

AU - Schopohl, Jochen

AU - Caron, Philippe

AU - Cuneo, Ross

AU - Kleinberg, David

AU - Colao, Annamaria

AU - Ruffin, Matthieu

AU - Hermosillo Reséndiz, Karina

AU - Hughes, Gareth

AU - Hu, Ke

AU - Barkan, Ariel

PY - 2014

Y1 - 2014

UR - http://www.scopus.com/inward/record.url?scp=84898791900&partnerID=8YFLogxK

U2 - 10.1007/s11102-013-0491-3

DO - 10.1007/s11102-013-0491-3

M3 - Article

AN - SCOPUS:84898791900

SN - 1386-341X

VL - 17

SP - 141

JO - Pituitary

JF - Pituitary

IS - 2

ER -

Erratum to: Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: Results from an open-ended, multicenter, Phase II extension study (Pituitary DOI: 10.1007/s11102-013-0478-0)

Access to Document

Other files and links

Cite this